In the severe group, patients treated with or without IVIG showed no statistically significant differences in age, gender, concurrent hypertension, diabetes mellitus, hepatitis, white blood cell count, neutrophil count, lymphocyte count, platelet count, PT, APTT, d‐dimer, ALT, AST, ALB, GLU, CK, and CK‐MB levels. This evidence concerns the gene GPT and Hepatitis.